KLOTZ, Laurence. Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists. Canadian Urological Association Journal, [S. l.], v. 1, n. 2S, 2012. DOI: 10.5489/cuaj.70. Disponível em: https://cuaj.ca/index.php/journal/article/view/70. Acesso em: 5 may. 2026.